Deal Making

Featured on Deal Making

Vector Bio and iBET team to scale-up gene delivery processes
Deal-Making
Vector Bio and iBET team to scale-up gene delivery processesVector Bio and iBET team to scale-up gene delivery processes

The project aims to develop Vector BioPharma’s gene delivery platform using iBET’s bioprocess and analytical methods.

byMillie Nelson
Jan 13, 2023
|
2 Min Read
Valo selects Exothera to develop oncolytic adenovirus
Deal-Making
Valo selects Exothera to develop oncolytic adenovirusValo selects Exothera to develop oncolytic adenovirus
byMillie Nelson
Jan 11, 2023
2 Min Read
Astrea adds chromatography offering through Delta buy
Deal-Making
Astrea adds chromatography offering through Delta buyAstrea adds chromatography offering through Delta buy
byMillie Nelson
Jan 10, 2023
2 Min Read
CytomX and Moderna partner to develop mRNA-based therapeutics
Deal-Making
CytomX and Moderna partner to develop mRNA-based therapeuticsCytomX and Moderna partner to develop mRNA-based therapeutics
byMillie Nelson
Jan 9, 2023
1 Min Read
MaxCyte signs electroporation deal with Catamaran
Deal-Making
MaxCyte signs electroporation deal with CatamaranMaxCyte signs electroporation deal with Catamaran
byMillie Nelson
Jan 6, 2023
2 Min Read
Sartorius and RoosterBio extend stem cell production partnership
Deal-Making
Sartorius and RoosterBio extend stem cell production partnershipSartorius and RoosterBio extend stem cell production partnership
byMillie Nelson
Jan 6, 2023
2 Min Read

More from Deal Making

Moderna makes first-ever acquisition with $85m OriCiro buy
Deal-Making
Moderna makes first-ever acquisition with $85m OriCiro buy
Moderna makes first-ever acquisition with $85m OriCiro buy
Jan 5, 2023
|
2 Min Read
byMillie Nelson
Kite and Arcellx partner to advance blood cancer cell therapy
Deal-Making
Kite and Arcellx partner to advance blood cancer cell therapy
Kite and Arcellx partner to advance blood cancer cell therapy
Jan 3, 2023
|
2 Min Read
byGareth Macdonald
ReiThera supports Sabin’s Ebola Sudan vax production
Deal-Making
ReiThera supports Sabin’s Ebola Sudan vax production
ReiThera supports Sabin’s Ebola Sudan vax production
Dec 21, 2022
|
2 Min Read
byMillie Nelson
Lets review 2022 - BioProcess Insider's Big M&A of the Year!
Deal-Making
Lets review 2022 - BioProcess Insider's Big M&A of the Year!
Lets review 2022 - BioProcess Insider's Big M&A of the Year!
Dec 21, 2022
|
1 Min Read
byMillie Nelson
CDMO deal drivers in 2022: Advanced therapies, RNA, and capacity
Deal-Making
CDMO deal drivers in 2022: Advanced therapies, RNA, and capacity
CDMO deal drivers in 2022: Advanced therapies, RNA, and capacity
Dec 20, 2022
|
4 Min Read
byGareth Macdonald
AGC and Gore enter Protein A-based partnership
Deal-Making
AGC and Gore enter Protein A-based partnership
AGC and Gore enter Protein A-based partnership
Dec 19, 2022
|
2 Min Read
byMillie Nelson
Andelyn to make first infantile neuroaxonal dystrophy gene therapy
Deal-Making
Andelyn to make first infantile neuroaxonal dystrophy gene therapy
Andelyn to make first infantile neuroaxonal dystrophy gene therapy
Dec 19, 2022
|
2 Min Read
byMillie Nelson
Inceptor Bio becomes third company to join Ori’s LEAP program
Deal-Making
Inceptor Bio becomes third company to join Ori’s LEAP program
Inceptor Bio becomes third company to join Ori’s LEAP program
Dec 15, 2022
|
2 Min Read
byMillie Nelson
Odimma to develop cancer therapy using Touchlight doggybone DNA tech
Deal-Making
Odimma to develop cancer therapy using Touchlight doggybone DNA tech
Odimma to develop cancer therapy using Touchlight doggybone DNA tech
Dec 12, 2022
|
2 Min Read
byMillie Nelson
Amgen looks to the Horizon with $27.8bn acquisition
Deal-Making
Amgen looks to the Horizon with $27.8bn acquisition
Amgen looks to the Horizon with $27.8bn acquisition
Dec 12, 2022
|
2 Min Read
byDan Stanton
Full-Life to acquire peptide firm Focus-X for $245m
Deal-Making
Full-Life to acquire peptide firm Focus-X for $245m
Full-Life to acquire peptide firm Focus-X for $245m
Dec 5, 2022
|
2 Min Read
byRichard Daverman
Touchlight receives $2.4m to advance doggybone DNA platform
Deal-Making
Touchlight receives $2.4m to advance doggybone DNA platform
Touchlight receives $2.4m to advance doggybone DNA platform
Dec 1, 2022
|
2 Min Read
byMillie Nelson
AstraZeneca laying cell therapy ambitions with $200m Neogene buy
Deal-Making
AstraZeneca laying cell therapy ambitions with $200m Neogene buy
AstraZeneca laying cell therapy ambitions with $200m Neogene buy
Nov 30, 2022
|
1 Min Read
byDan Stanton
Sartorius and Exopharm to develop large-scale exosome tech
Deal-Making
Sartorius and Exopharm to develop large-scale exosome tech
Sartorius and Exopharm to develop large-scale exosome tech
Nov 28, 2022
|
2 Min Read
byMillie Nelson
Healiva to speed regenerative skin therapy launch with B.Braun asset buy
Deal-Making
Healiva to speed regenerative skin therapy launch with B.Braun asset buy
Healiva to speed regenerative skin therapy launch with B.Braun asset buy
Nov 24, 2022
|
1 Min Read
byMillie Nelson
RVAC and A*STAR partner to build mRNA capabilities in Singapore
Deal-Making
RVAC and A*STAR partner to build mRNA capabilities in Singapore
RVAC and A*STAR partner to build mRNA capabilities in Singapore
Nov 23, 2022
|
2 Min Read
byMillie Nelson
iBio to divest CDMO biz and lose 60% of its workforce
Deal-Making
iBio to divest CDMO biz and lose 60% of its workforce
iBio to divest CDMO biz and lose 60% of its workforce
Nov 11, 2022
|
3 Min Read
byMillie Nelson
CSL Seqirus to access Arcturus’ sa-mRNA vax tech
Deal-Making
CSL Seqirus to access Arcturus’ sa-mRNA vax tech
CSL Seqirus to access Arcturus’ sa-mRNA vax tech
Nov 4, 2022
|
2 Min Read
byMillie Nelson
Celltrion bulks out ADC ambition with Pinot tech deal
Deal-Making
Celltrion bulks out ADC ambition with Pinot tech deal
Celltrion bulks out ADC ambition with Pinot tech deal
Oct 21, 2022
|
1 Min Read
byDan Stanton
Samsung Biologics wins $296m 10-year GSK contract
Deal-Making
Samsung Biologics wins $296m 10-year GSK contract
Samsung Biologics wins $296m 10-year GSK contract
Oct 20, 2022
|
2 Min Read
byDan Stanton
Lilly $487m+ Akouos buy to add hearing loss gene therapy programs
Deal-Making
Lilly $487m+ Akouos buy to add hearing loss gene therapy programs
Lilly $487m+ Akouos buy to add hearing loss gene therapy programs
Oct 18, 2022
|
2 Min Read
byDan Stanton
Inceptor and Avectas team to improve CAR-T manufacturing
Deal-Making
Inceptor and Avectas team to improve CAR-T manufacturing
Inceptor and Avectas team to improve CAR-T manufacturing
Oct 14, 2022
|
1 Min Read
byMillie Nelson
BioNTech heads down under to build mRNA plant
Facilities & Capacity
BioNTech heads down under to build mRNA plant
BioNTech heads down under to build mRNA plant
Oct 11, 2022
|
2 Min Read
byMillie Nelson
Intravacc bags two intranasal vaccine deals in one week
Deal-Making
Intravacc bags two intranasal vaccine deals in one week
Intravacc bags two intranasal vaccine deals in one week
Oct 10, 2022
|
3 Min Read
byMillie Nelson
Ginkgo adds ‘circular’ RNA with Circularis buy
Deal-Making
Ginkgo adds ‘circular’ RNA with Circularis buy
Ginkgo adds ‘circular’ RNA with Circularis buy
Oct 7, 2022
|
2 Min Read
byMillie Nelson
Cytiva snaps up Cevec, boosting cell line and viral vector services
Deal-Making
Cytiva snaps up Cevec, boosting cell line and viral vector services
Cytiva snaps up Cevec, boosting cell line and viral vector services
Oct 6, 2022
|
2 Min Read
byDan Stanton
Boehringer Ingelheim rolls out VR training at fill-finish facilities
Bioprocess Insider
Boehringer Ingelheim rolls out VR training at fill-finish facilities
Boehringer Ingelheim rolls out VR training at fill-finish facilities
Sep 30, 2022
|
2 Min Read
byMillie Nelson
Rocket bolsters AAV pipeline with Renovacor buy
Deal-Making
Rocket bolsters AAV pipeline with Renovacor buy
Rocket bolsters AAV pipeline with Renovacor buy
Sep 30, 2022
|
2 Min Read
byMillie Nelson
Valneva and IDT Biologika end COVID vaccine CDMO contract
Deal-Making
Valneva and IDT Biologika end COVID vaccine CDMO contract
Valneva and IDT Biologika end COVID vaccine CDMO contract
Sep 23, 2022
|
1 Min Read
byDan Stanton
Beckman Coulter bolsters analytical capabilities with ValitaCell buy
Deal-Making
Beckman Coulter bolsters analytical capabilities with ValitaCell buy
Beckman Coulter bolsters analytical capabilities with ValitaCell buy
Sep 14, 2022
|
2 Min Read
byMillie Nelson

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency
Register Now: Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency
Ask the Expert webcasts
ATE Webcasts
Register Now: Introduction to Lonza CHO Media Portfolio: Harnessing Simplicity with the TheraPRO® CHO Media System
Register Now: Introduction to Lonza CHO Media Portfolio: Harnessing Simplicity with the TheraPRO® CHO Media System
Ask the Expert webcasts
ATE Webcasts
Register Now: Out of the Box Computer Software Assurance with ValGenesis VLMS
Register Now: Out of the Box Computer Software Assurance with ValGenesis VLMS
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Repligen white paper
Sponsored Content
30% Increase in Concentration Accuracies with KrosFlo® RS 30 RPM™ TFF System
30% Increase in Concentration Accuracies with KrosFlo® RS 30 RPM™ TFF System

Oct 25, 2024

Solventum white paper
Sponsored Content
3M™ Harvest RC Centrate Chromatographic Clarifier: Evolving the Role of Clarification in the Biopharmaceutical Manufacturing Process
3M™ Harvest RC Centrate Chromatographic Clarifier: Evolving the Role of Clarification in the Biopharmaceutical Manufacturing Process

Oct 25, 2024

Tosoh AEX Method
Sponsored Content
Improved Safety in Ion Exchange Chromatography for Empty/Full Adeno-Associated Virus Analysis
Improved Safety in Ion Exchange Chromatography for Empty/Full Adeno-Associated Virus Analysis

Oct 14, 2024